Farini et al., 2021 - Google Patents
Defective dystrophic thymus determines degenerative changes in skeletal muscleFarini et al., 2021
View HTML- Document ID
- 9690659166981321363
- Author
- Farini A
- Sitzia C
- Villa C
- Cassani B
- Tripodi L
- Legato M
- Belicchi M
- Bella P
- Lonati C
- Gatti S
- Cerletti M
- Torrente Y
- Publication year
- Publication venue
- Nature communications
External Links
Snippet
In Duchenne muscular dystrophy (DMD), sarcolemma fragility and myofiber necrosis produce cellular debris that attract inflammatory cells. Macrophages and T-lymphocytes infiltrate muscles in response to damage-associated molecular pattern signalling and the …
- 210000001541 Thymus Gland 0 title abstract description 118
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1712—Not used, see subgroup
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ko et al. | Mesenchymal stem and stromal cells harness macrophage-derived amphiregulin to maintain tissue homeostasis | |
| Farini et al. | Defective dystrophic thymus determines degenerative changes in skeletal muscle | |
| Povero et al. | Human induced pluripotent stem cell–derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis | |
| Li et al. | Graft IL-33 regulates infiltrating macrophages to protect against chronic rejection | |
| Kojima et al. | Exosomes in postshock mesenteric lymph are key mediators of acute lung injury triggering the macrophage activation via Toll‐like receptor 4 | |
| Shi et al. | Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer’s disease | |
| US11331328B2 (en) | Compositions and methods for inhibiting antiapoptotic Bcl-2 proteins as anti-aging agents | |
| Jarry et al. | Mucosal IL-10 and TGF-β play crucial roles in preventing LPS-driven, IFN-γ–mediated epithelial damage in human colon explants | |
| Seeliger et al. | Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases | |
| Moroncini et al. | Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice | |
| Azar et al. | Preimplantation factor reduces graft-versus-host disease by regulating immune response and lowering oxidative stress (murine model) | |
| Yeagy et al. | Kidney preservation by bone marrow cell transplantation in hereditary nephropathy | |
| Yip et al. | Docosahexaenoic acid reduces microglia phagocytic activity via miR-124 and induces neuroprotection in rodent models of spinal cord contusion injury | |
| Kamdar et al. | Innate recognition of the microbiota by TLR1 promotes epithelial homeostasis and prevents chronic inflammation | |
| Kennedy et al. | Inflammatory changes in bone marrow microenvironment associated with declining B lymphopoiesis | |
| Chen et al. | mTOR signaling regulates protective activity of transferred CD4+ Foxp3+ T cells in repair of acute kidney injury | |
| Wang et al. | Prophylactic supplementation with lactobacillus reuteri or its metabolite GABA protects against acute ischemic cardiac injury | |
| Ma et al. | CD226 knockout alleviates high-fat diet induced obesity by suppressing proinflammatory macrophage phenotype | |
| Yan et al. | The effect of caloric restriction on the increase in senescence-associated T cells and metabolic disorders in aged mice | |
| WO2015025956A1 (en) | Pharmaceutical composition for treating myocardial damage, pharmaceutical composition for preventing myocardial damage, pharmaceutical composition for treating heart failure, pharmaceutical composition for preventing heart failure, method for treating or preventing myocardial damage or heart failure, mfg-e8, uses of mfg-e8, and method for screening compounds for treating or preventing myocardial damage or heart failure | |
| Collins-Hooper et al. | Propeptide-mediated inhibition of myostatin increases muscle mass through inhibiting proteolytic pathways in aged mice | |
| Zhang et al. | Protective effect of Astragalus polysaccharide on endothelial progenitor cells injured by thrombin | |
| KR102100307B1 (en) | Isolation and use of human lymphoid organ-derived suppressive stromal cells | |
| Dhaeze et al. | Sex-dependent factors encoded in the immune compartment dictate relapsing or progressive phenotype in demyelinating disease | |
| EP2918289A1 (en) | MEDICINE COMPRISING MODULATOR OF ACTIVITY OF CD300a-EXPRESSING CELL ASSOCIATED WITH ALLERGIC DISEASE, CD300a GENE KNOCK-OUT MOUSE, AND USE OF MODULATOR OF ACTIVITY OF CD300a-EXPRESSING CELL |